Sensitive Detection and Enumeration of CD34+ Cells in Peripheral and Cord Blood by Flow Cytometry
Overview
Affiliations
Peripheral blood stem cell autografts are increasingly used to reconstitute hematopoiesis after intensive, potentially marrow-ablative therapy. Assessment of autograft adequacy by enumeration of hematopoietic progenitors in colony-forming assays is handicapped by lack of reproducibility and prolonged assay time. Alternative approaches of graft assessment by flow-cytometric enumeration of stem/progenitor cells bearing the CD34 antigen can be hampered by low specificity and sensitivity. Here, we report a rapid and reliable multiparameter flow-cytometric approach to accurately enumerate CD34+ cells in peripheral blood (PB) mononuclear cells (MNCs). Total nucleated white blood cells (WBCs) are quantified by staining with fluorescein isothiocyanate (FITC)-conjugated CD45 antibody. Simultaneous staining by phycoerythrin (PE)-conjugated CD34 antibody defines an approximate number for the CD34+ progenitor/stem cell subfraction. When starting CD34+ cell numbers are low (0.01-0.5%), other nonspecifically stained leukocytes make accurate enumeration impossible. However, when the CD34+ fraction is analyzed for CD45 expression vs. side scatter (granularity), true CD34+ blast cells form a discrete cluster exhibiting low-density CD45 expression and low side-scatter characteristics. Cells within this "blast region" can be readily distinguished from lymphocytes, monocytes, granulocytes, and other events that can contaminate the CD34+ population. Here, we used this sensitive procedure to enumerate CD34+ cells in steady-state PB samples (0.03-0.09%), normal bone marrow (BM) aspirates, and umbilical cord blood collections (0.33-1.98%). This approach thus provides a means to analyze CD34+ cells in specimens from patients who have been extensively treated with chemotherapy and those undergoing PB stem cell mobilization with cytokines. Additionally, it is useful for assessment of CD34+ cells in a variety of clinical samples exhibiting perturbations of the hematopoietic progenitor/stem cell compartments.
Wang D, Wang X, Ba H, Ren J, Wang Z, Sun H Life Med. 2025; 2(1):lnac021.
PMID: 39872959 PMC: 11749460. DOI: 10.1093/lifemedi/lnac021.
Jelic T, Estalilla O, Vos J, Harvey G, Stricker C, Adelanwa A J Blood Med. 2023; 14:519-535.
PMID: 37753388 PMC: 10519426. DOI: 10.2147/JBM.S417432.
Nguyen K, Hoang N, Nguyen H, Thanh L BMC Neurol. 2023; 23(1):37.
PMID: 36690963 PMC: 9869514. DOI: 10.1186/s12883-023-03071-3.
Watt A, Kirkland M, Nekkanti L, Pham Y, McDonald C, Malhotra A Cell Tissue Res. 2022; 388(1):117-132.
PMID: 35106623 PMC: 8976778. DOI: 10.1007/s00441-022-03592-2.
Duan W, Dou X, Lei L, Wang F, Huang X, Lu J Zhonghua Xue Ye Xue Za Zhi. 2021; 42(1):21-26.
PMID: 33677864 PMC: 7957246. DOI: 10.3760/cma.j.issn.0253-2727.2021.01.005.